exercise programme for group with ECOG 0-1
Procedureexercise programme for group with ECOG 2
NCT Number: NCT06825429
The aim of this study to investigate the feasibility in hospital reality, of a group exercise program for oncology patients under active treatment and evaluate its impact on some outcomes considered relevant from both clinical and subjective point of view.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
The intervention will consist of EFG sessions lasting 45 minutes each, twice a week for 12 weeks to be carried out in the gym of the Rehabilitation Day Hospital.
Each 45-minute session includes an initial relaxation/stretching phase, simple aerobic exercises, muscle strengthening exercises, balance exercises, and will be led by a physiotherapist. The exercises proposed to the group with ECOG 2 will be less intense and of less difficulty with the aim of adapting the activity to patients with a lower performance status (see appendix 4.5, V2, 07/10/2024). The groups will consist of a minimum of five patients and a maximum of ten. Patients will also be stimulated to perform physical activity at home to a total of 150 minutes per week. Patients will be assessed at baseline (T0), at the end of the intervention (T1,12 weeks) and 6 months after the start of the intervention (T2).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
exercise programme for group with ECOG 2
this intervention shall be proportionated to the ECOG status of the group
Time frame: through study completion, an average of 2 years
overall adherence to the group exercise programme > 40%
Time frame: through study completion, an average of 2 years
The frequency of at least 70% of the exercise sessions foreseen by the programme.
Time frame: through study completion, an average of 2 years
Questionnaire in which patients have to describe quality of life during study treatment
Time frame: through study completion, an average of 2 years
The effect of the EFG program on mood tone and physical function
Contact information is provided by the study sponsor or research team.
Besa Kopliku, MD
CONTACT
Letizia Circosta, PT
CONTACT
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02159742
Neoplasms, Neoplastic Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04084067
Adenocarcinoma, Carcinoma
Memphis, Tennessee, United States
View Trial DetailsNCT07100730
Astrocytoma, Brain Diseases
Gold Coast, Queensland, Australia
View Trial DetailsNCT05450744
Astrocytoma, Glioblastoma
Sydney, New South Wales, Australia
View Trial Details